Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea.
So Young ParkSe Hwa KimTae-Young KimYoung Kyun LeeYong Chan HaSunmee JangSeong Hee AhnHa Young KimPublished in: Journal of Korean medical science (2021)
SERMs did not increase the risk of VTE compared to BPs in Koreans with osteoporosis. However, old age and estrogen replacement both increased VTE risk.